Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
128.00    0.50 (0.39%)
Bid:
128.00
Ask:
131.50
Spread: 3.50 (2.734%)
Market Cap: £203.93m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Trading Update

27 Oct 2021 07:00

RNS Number : 3517Q
Redcentric PLC
27 October 2021
 

Redcentric plc

("Redcentric" or the "Company")

Trading Update

Redcentric plc (AIM: RCN), a leading UK IT managed services provider, today announces a pre-close trading update for the six months ended 30 September 2021.

Financial Highlights

We are pleased to announce that trading for the six months ended 30 September 2021 is expected to be in line with the Board's expectations, with revenues of £46.4m (H1 FY21: £46.2m) and adjusted EBITDA of £12.0m (H1 FY21: £12.3m). The Company had minimal net debt of £0.4m at 30 September 2021 (31 March 2021: net cash of £1.0m), excluding supplier loans and leases previously classified as operating leases under IAS17. This strong position reflects a final dividend payment of £3.7m, the disposal of the non-core EDF contract for £5.8m and the acquisition of Piksel Industry Solutions Ltd ("Piksel IS") for £9.5m.

Operational Highlights

The integration of Piksel IS is progressing well, and we are on target to have the business fully integrated by the end of the current financial year. Good progress has been made in realising synergies and we are confident of achieving cost savings of at least £1.1m. The acquisition has been well received by both companies' customer bases and we are already in active discussions regarding several cross-sell opportunities.

Outlook

We expect trading for the year ending 31 March 2022 to be in line with the Board's expectations, including strong cash generation consistent with previous guidance. This is despite a continued lack of largescale IT projects and supply chain issues remaining a feature of the sector. In addition, several of our electricity supply contracts fell due for renewal during the ongoing UK energy crisis and this will add £0.5m of costs to H2 FY22 and at least £0.5m of costs to H1 FY23.

We continue to make progress on M&A prospecting, with several active conversations underway, a growing pipeline of potential targets and a strong balance sheet.

Notice of Interim results

The Company intends to announce its results for the six months ended 30 September 2021 on Thursday 18 November 2021.

 

Enquiries:

Redcentric plc +44 (0)800 983 2522

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

finnCap Ltd - Nomad and Broker +44 (0)20 7220 0500

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGMCUUPGGRQ
Date   Source Headline
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company
15th Nov 20227:00 amRNSTrading Update
2nd Nov 20227:00 amRNSExercise of Options
26th Oct 20227:00 amRNSExercise of Options
19th Oct 20227:00 amRNSExercise of Options
13th Oct 20222:06 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSGrant of Options and Director/PDMR Shareholding
5th Oct 202210:57 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSExercise of Options
16th Sep 202212:36 pmRNSHolding(s) in Company
15th Sep 202212:54 pmRNSHolding(s) in Company
15th Sep 202212:25 pmRNSExercise of Options and PDMR Shareholding
14th Sep 20227:00 amRNSExercise of Options
13th Sep 202211:52 amRNSHolding(s) in Company
7th Sep 20224:28 pmRNSResult of AGM
6th Sep 20227:00 amRNSExercise of Options
5th Sep 20221:53 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSSave As You Earn Share Option Scheme
30th Aug 20227:00 amRNSExercise of Options
23rd Aug 20229:23 amRNSExercise of Options
17th Aug 20227:00 amRNSExercise of Options
8th Aug 20227:00 amRNSPublication of Annual Report and Notice of AGM
1st Aug 202212:10 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSExercise of Options
22nd Jul 202212:08 pmRNSHolding(s) in Company
21st Jul 20227:01 amRNSAlan Aubrey - AIM Rule 17 Disclosures
21st Jul 20227:00 amRNSPreliminary results announcement FY22

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.